文献速递复苏、休克与脓毒症

失血性休克的实验模型:休克严重程度对内皮病变的影响

Experimental Models of Endotheliopathy: Impact of Shock Severity.
PubMed 文献 · Shock · 2018-01-01
一句话结论大鼠失血性休克未复苏即已发生内皮病变,其强度与休克严重程度及交感肾上腺激活相关,可用碱缺失和乳酸标化模型。

该研究在大鼠中比较了两种失血性休克模型:固定放血40%总血容量的容量控制组(v-HS)与以碱缺失>5.5 mmol/L和/或乳酸>2.2 mmol/L为目标的实验室引导压力控制组(l-HS)。休克终点时l-HS组碱缺失和乳酸更高,sVEGFR-1、syndecan-1及肾上腺素升高幅度均约为v-HS组的2倍。线性回归显示休克严重程度(碱缺失)与syndecan-1、sVEGFR1及肾上腺素独立相关。作者认为内皮病变在未再灌注的失血性休克阶段即已发生,其强度与休克严重程度及交感肾上腺激活密切相关,并可用碱缺失和/或乳酸等生物学终点标化失血性休克模型。

要点

  • 大鼠失血性休克未复苏阶段即出现内皮损伤标志物sVEGFR-1和syndecan-1升高,提示内皮病变不依赖再灌注。
  • l-HS组较v-HS组休克更重:碱缺失9.5±2.5 vs. 3.0±1.0 mmol/L(P<0.001),乳酸4.1±1.3 vs. 1.6±0.6 mmol/L(P<0.001)。
  • l-HS组sVEGFR-1和syndecan-1较基线变化分别约160±10% vs. 116±36%(P<0.01)和170±37% vs. 113±27%(P<0.001),约为v-HS组的2倍。
  • l-HS组肾上腺素升高幅度为v-HS组的2倍(1964±961% vs. 855±451%,P<0.02)。
  • 线性回归显示碱缺失与syndecan-1(rho=0.55,P=0.0005)、sVEGFR1(rho=0.25,P<0.05)及肾上腺素(rho=0.31,P=0.021)独立相关。

适用人群与场景

  • 大鼠失血性休克模型,未涉及人类患者。

诊断标准与关键阈值

  • 实验室引导失血性休克(l-HS)目标:碱缺失>5.5 mmol/L和/或乳酸>2.2 mmol/L,采用压力控制放血。
  • 容量控制失血性休克(v-HS):放血40%总血容量。

研究设计与关键结果

  • 研究类型:大鼠实验研究;比较容量控制失血性休克(v-HS,放血40%总血容量)与实验室引导失血性休克(l-HS,以碱缺失>5.5 mmol/L和/或乳酸>2.2 mmol/L为目标行压力控制放血)。
  • 休克终点平均动脉压:v-HS组36±5.6 mmHg vs. l-HS组30±3.0 mmHg,v-HS组显著更高(P<0.01)。
  • 休克终点碱缺失:l-HS组9.5±2.5 mmol/L vs. v-HS组3.0±1.0 mmol/L,l-HS组更高(P<0.001);乳酸:l-HS组4.1±1.3 mmol/L vs. v-HS组1.6±0.6 mmol/L,l-HS组更高(P<0.001)。
  • sVEGFR-1较基线变化:l-HS组160±10% vs. v-HS组116±36%,l-HS组约高50%(P<0.01);syndecan-1较基线变化:l-HS组170±37% vs. v-HS组113±27%,l-HS组约高50%(P<0.001)。
  • 肾上腺素较基线变化:l-HS组1964±961% vs. v-HS组855±451%,l-HS组为v-HS组的2倍(P<0.02)。
  • 线性回归分析显示碱缺失与syndecan-1(rho=0.55,P=0.0005)、sVEGFR1(rho=0.25,P<0.05)及肾上腺素(rho=0.31,P=0.021)独立相关。

证据类型、等级与局限

  • 证据类型:大鼠实验研究(动物实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为内皮病变在失血性休克未再灌注阶段即已发生,其强度与休克严重程度及交感肾上腺激活密切相关。
  • 作者认为在失血性休克模型中可用碱缺失和/或乳酸等生物学终点对休克严重程度进行标化和标准化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Hemorrhagic shock (HS) followed by resuscitation is often associated with sympathoadrenal activation (SAA) and endothelial damage (ED).

OBJECTIVE: We aimed to evaluate the impact of HS alone on the magnitude of SAA and consecutive ED, and to characterize potential targets for a standardized and reproducible model of HS-induced endotheliopathy in rats.

METHODS: Rats were subjected either to a volume-controlled HS (40% of total blood volume: v-HS group) or to a laboratory-guided HS (l-HS) targeting base deficit (BD) more than 5.5 mmol/L and/or lactate more than 2.2 mmol/L using a pressure-controlled volume loss.

RESULTS: At the end of shock, mean arterial pressure was significantly higher in the v-HS than the l-HS group (36 ± 5.6 vs. 30 ± 3.0 mmHg; P < 0.01). Base deficit and lactate were higher in l-HS than the v-HS group (BD: 9.5 ± 2.5 vs. 3.0 ± 1.0 mmol/L; P < 0.001; lactate: 4.1 ± 1.3 vs. 1.6 ± 0.6 mmol/L; P < 0.001). sVEGFR-1 and syndecan-1 were approximately 50% higher in the l-HS than the v-HS group (% changes vs. baseline: 160 ± 10 vs. 116 ± 36; P < 0.01; 170 ± 37 vs. 113 ± 27; P < 0.001). Adrenaline was 2-fold higher in l-HS than the v-HS group (1964 ± 961% vs. 855 ± 451%; P < 0.02, respectively). Moreover, linear regression analysis revealed an independent association of shock severity BD with syndecan-1 (rho = 0.55, P = 0.0005), sVEGFR1 (rho = 0.25, P < 0.05), and adrenaline (rho = 0.31, P = 0.021).

CONCLUSIONS: Our findings indicate that ED has already occurred during HS without reperfusion; intensity is strongly related to the severity of HS and consecutive SAA; and severity may appropriately be targeted and standardized in a HS model controlled by biological endpoints such as BD and/or lactate.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Hofmann N, Zipperle J, Jafarmadar M, et al. Experimental Models of Endotheliopathy: Impact of Shock Severity. Shock. 2018. PMID: 28697004. doi:10.1097/SHK.0000000000000944

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。